Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Curry

Showing results (181-190 of 210) with videos related to

Pageof 21
Sort By:
Hepatology (Baltimore, Md.)|August 18, 2016
Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort studyElliot B Tapper, Bruce R Bacon, Michael P Curry, et al.
Journal of Viral Hepatitis|October 13, 2016
Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health studyE B Tapper, B R Bacon, M P Curry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2021
Fresh frozen plasma transfusion in acute variceal haemorrhage: Results from a multicentre cohort studyArpan Mohanty, Devika Kapuria, Andrew Canakis, et al.
Plos One|August 1, 2019
Multi-pathogen serological survey of migratory caribou herds: A snapshot in timeA M Carlsson, P Curry, B Elkin, et al.
Clinical Transplantation|August 18, 2009
Timing of sirolimus conversion influences recovery of renal function in liver transplant recipientsChristin C Rogers, Scott R Johnson, Didier A Mandelbrot, et al.
Gastroenterology|March 15, 2018
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus InfectionOmar El-Sherif, Z Gordon Jiang, Elliot B Tapper, et al.
Gastroenterology|January 31, 2012
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferonJosh Levitsky, Maria Isabel Fiel, John P Norvell, et al.
Hepatology Communications|April 21, 2022
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamideCalvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, et al.
Plos One|July 15, 2016
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus InfectionMing V Lin, Meghan E Sise, Martha Pavlakis, et al.
Radiology|May 7, 2024
Efficacy and Safety of Radiation Segmentectomy with <sup>90</sup>Y Resin Microspheres for Hepatocellular CarcinomaAmmar Sarwar, M Saad Malik, Nhi H Vo, et al.
Pageof 21

Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|August 18, 2016
Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort studyElliot B Tapper, Bruce R Bacon, Michael P Curry, et al.
Journal of Viral Hepatitis|October 13, 2016
Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health studyE B Tapper, B R Bacon, M P Curry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2021
Fresh frozen plasma transfusion in acute variceal haemorrhage: Results from a multicentre cohort studyArpan Mohanty, Devika Kapuria, Andrew Canakis, et al.
Plos One|August 1, 2019
Multi-pathogen serological survey of migratory caribou herds: A snapshot in timeA M Carlsson, P Curry, B Elkin, et al.
Clinical Transplantation|August 18, 2009
Timing of sirolimus conversion influences recovery of renal function in liver transplant recipientsChristin C Rogers, Scott R Johnson, Didier A Mandelbrot, et al.
Gastroenterology|March 15, 2018
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus InfectionOmar El-Sherif, Z Gordon Jiang, Elliot B Tapper, et al.
Gastroenterology|January 31, 2012
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferonJosh Levitsky, Maria Isabel Fiel, John P Norvell, et al.
Hepatology Communications|April 21, 2022
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamideCalvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, et al.
Plos One|July 15, 2016
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus InfectionMing V Lin, Meghan E Sise, Martha Pavlakis, et al.
Radiology|May 7, 2024
Efficacy and Safety of Radiation Segmentectomy with <sup>90</sup>Y Resin Microspheres for Hepatocellular CarcinomaAmmar Sarwar, M Saad Malik, Nhi H Vo, et al.
Pageof 21